4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055725
Director sold 26,468 shares at an average $29.23 ($773,720)
From the SEC's structured data for this filing
Trades in this filing
GADICKE ANSBERT · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-09 | Sale : show line 1 in the form | −1,898 | $29.35 | $55,706 | 248,170 | D |
| 2021-09-09 | Sale : show line 2 in the form | −13,727 | $29.35 | $402,887 | 7,674,449 | I |
| 2021-09-10 | Sale : show line 3 in the form | −820 | $29.04 | $23,813 | 247,350 | D |
| 2021-09-10 | Sale : show line 4 in the form | −5,931 | $29.04 | $172,236 | 7,668,518 | I |
| 2021-09-13 | Sale : show line 5 in the form | −497 | $29.10 | $14,463 | 246,853 | D |
| 2021-09-13 | Sale : show line 6 in the form | −3,595 | $29.10 | $104,615 | 7,664,923 | I |
| Open-market sales · 26,468 sh · avg $29.23 · $773,720 | ||||||
Loading xslF345X03/doc4.xml…